Bliss GVS Pharma Ltd Annually Results

Gross Sales

809.73

770.24

751.59

747.45

577.21

Excise Duty

0

0

0

0

0

Net Sales

809.73

770.24

751.59

747.45

577.21

Other Operating Income

0

0

0

0

0

Other Income

36.49

28.74

17.79

31.49

20.22

Total Income

846.22

798.98

769.37

778.95

597.43

Total Expenditure

683.04

648.82

634.27

702.71

470.56

PBIDT

163.18

150.16

135.11

76.24

126.87

Interest

8.12

6.91

10.36

4.74

5.51

PBDT

155.06

143.25

124.74

71.5

121.36

Depreciation

29.42

26.38

18.67

17.33

17.23

Minority Interest Before NP

0

0

0

0

0

Tax

39.38

33.26

40.84

35.78

28.92

Deferred Tax

-3.99

2.03

-11.51

-4.74

1.23

Reported Profit After Tax

90.26

81.58

76.73

23.13

73.97

Minority Interest After NP

5.96

6.12

5.88

8.09

5.48

Net Profit after Minority Interest

84.3

75.45

70.86

15.04

68.49

Extra-ordinary Items

0

-20.38

0

-37.81

0

Adjusted Profit After Extra-ordinary item

84.3

95.83

70.86

52.85

68.49

EPS (Unit Curr.)

8.02

7.23

6.83

1.46

6.64

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

50

50

50

50

50

Equity

10.54

10.47

10.42

10.37

10.31

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

20.15

19.49

17.97

10.2

21.97

PBDTM(%)

19.14

18.59

16.59

9.56

21.02

PATM(%)

11.14

10.59

10.2

3.09

12.81